$91.04
-4.43-4.64%
At close: -
$91.04
0.000.00%
After Hours: 4:34 PM EDT
Comments
Loading...
GeneDx Holdings Analyst Ratings and Price Targets | NASDAQ:WGS | Benzinga
GeneDx Holdings Corp has a consensus price target of $82.6 based on the ratings of 5 analysts. The high is $118 issued by TD Cowen on January 7, 2025. The low is $45 issued by BTIG on July 31, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, TD Cowen, and Goldman Sachs on February 19, 2025, January 7, 2025, and October 30, 2024, respectively. With an average price target of $89.33 between Goldman Sachs, TD Cowen, and Goldman Sachs, there's an implied -1.87% downside for GeneDx Holdings Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
TD Cowen
Wells Fargo
Craig-Hallum
BTIG
1calculated from analyst ratings
Analyst Ratings for GeneDx Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/19/2025 | Buy Now | -12.13% | Goldman Sachs | Matthew Sykes66% | $70 → $80 | Maintains | Neutral | Get Alert |
| 01/07/2025 | Buy Now | 29.61% | TD Cowen | Dan Brennan65% | $75 → $118 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | -23.11% | Goldman Sachs | Matthew Sykes66% | $54 → $70 | Maintains | Neutral | Get Alert |
| 10/30/2024 | Buy Now | -17.62% | Wells Fargo | Brandon Couillard70% | $34 → $75 | Maintains | Equal-Weight | Get Alert |
| 10/30/2024 | Buy Now | 4.35% | Craig-Hallum | Bill Bonello69% | $70 → $95 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | -23.11% | Craig-Hallum | Bill Bonello69% | $46 → $70 | Maintains | Buy | Get Alert |
| 10/16/2024 | Buy Now | -40.69% | Goldman Sachs | Matthew Sykes66% | $32 → $54 | Maintains | Neutral | Get Alert |
| 08/27/2024 | Buy Now | -62.65% | Wells Fargo | Brandon Couillard70% | → $34 | Initiates | → Equal-Weight | Get Alert |
| 07/31/2024 | Buy Now | -45.08% | TD Cowen | Dan Brennan65% | $46 → $50 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | -50.57% | BTIG | Mark Massaro67% | $35 → $45 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | -49.47% | Craig-Hallum | Bill Bonello69% | $43 → $46 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | -64.85% | Goldman Sachs | Matthew Sykes66% | $28 → $32 | Maintains | Neutral | Get Alert |
| 07/17/2024 | Buy Now | -69.24% | Goldman Sachs | Matthew Sykes66% | $12.5 → $28 | Maintains | Neutral | Get Alert |
| 07/10/2024 | Buy Now | -52.77% | Craig-Hallum | Bill Bonello69% | → $43 | Initiates | → Buy | Get Alert |
| 06/26/2024 | Buy Now | -61.56% | BTIG | Mark Massaro67% | $19 → $35 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | -73.64% | TD Cowen | Dan Brennan65% | $14 → $24 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | -79.13% | BTIG | Mark Massaro67% | $15 → $19 | Maintains | Buy | Get Alert |
| 04/22/2024 | Buy Now | -83.52% | BTIG | Mark Massaro67% | $11 → $15 | Maintains | Buy | Get Alert |
| 04/15/2024 | Buy Now | -87.92% | Goldman Sachs | Matthew Sykes66% | $6 → $11 | Maintains | Neutral | Get Alert |
| 11/01/2023 | Buy Now | -93.41% | Goldman Sachs | Matthew Sykes66% | $7 → $6 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | -92.31% | Goldman Sachs | Matthew Sykes66% | $8 → $7 | Maintains | Neutral | Get Alert |
| 07/24/2023 | Buy Now | -91.21% | Goldman Sachs | Matthew Sykes66% | $9 → $8 | Maintains | Neutral | Get Alert |
| 07/21/2023 | Buy Now | -91.21% | Goldman Sachs | Matthew Sykes66% | $9 → $8 | Maintains | Neutral | Get Alert |
| 05/15/2023 | Buy Now | -90.11% | Goldman Sachs | Matthew Sykes66% | $33 → $9 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for GeneDx Holdings (WGS) stock?
The latest price target for GeneDx Holdings (NASDAQ:WGS) was reported by Goldman Sachs on February 19, 2025. The analyst firm set a price target for $80.00 expecting WGS to fall to within 12 months (a possible -12.13% downside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GeneDx Holdings (WGS)?
The latest analyst rating for GeneDx Holdings (NASDAQ:WGS) was provided by Goldman Sachs, and GeneDx Holdings maintained their neutral rating.
When was the last upgrade for GeneDx Holdings (WGS)?
There is no last upgrade for GeneDx Holdings
When was the last downgrade for GeneDx Holdings (WGS)?
There is no last downgrade for GeneDx Holdings.
When is the next analyst rating going to be posted or updated for GeneDx Holdings (WGS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GeneDx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GeneDx Holdings was filed on February 19, 2025 so you should expect the next rating to be made available sometime around February 19, 2026.
Is the Analyst Rating GeneDx Holdings (WGS) correct?
While ratings are subjective and will change, the latest GeneDx Holdings (WGS) rating was a maintained with a price target of $70.00 to $80.00. The current price GeneDx Holdings (WGS) is trading at is $91.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
